About IMIQUIMOD 5%W/W
Topical immune response modifier
Used for
- Treats external genital and anal warts
- Treats actinic keratoses and superficial basal cell carcinoma
Usual adult dose
Genital warts: apply three times weekly until cleared, up to 16 weeks. Other conditions use different schedules.
Common side effects
- Redness, swelling, itching, burning, or soreness at application site
- Skin peeling, scabbing, or sores
- Headache or flu-like symptoms
Important warnings
- Use only on the affected skin; avoid eyes, mouth, and broken skin.
- Severe skin reactions can occur; treatment may need interruption.
- For genital or anal warts, avoid sexual contact while cream is on skin.
- May weaken condoms and diaphragms; avoid sexual contact until washed off.
Pregnancy
Human pregnancy data are limited; use only if clearly needed after clinician assessment.
Breastfeeding
It is unknown whether imiquimod passes into breast milk; avoid applying where an infant may contact it.
Interactions
- No important drug interactions are established; tell clinicians about other treatments applied to the same area.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.